Source: Eden Innovations
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Eden Innovations’ (EDE) subsidiary appoints a sales agent for its EdenCrete product range in Indonesia
  • Eden Innovations LLC has appointed PT Bangun Akal Indonesia, trading as Building Ai Indonesia, as its sales agent for a two-year term
  • Through the appointment, Ai Building will provide full sales support and introduce customers, and will receive a commission on sales to any customers it introduces
  • Eden Innovations is up 5.88 per cent, trading at 1.8 cents per share at 12:45 pm AEDT

Eden Innovations’ (EDE) subsidiary has appointed a sales agent for its EdenCrete product range in Indonesia.

EdenCrete is a carbon-strengthened concrete additive that enhances a wide range of performance characteristics of concrete.

Eden Innovations LLC has appointed PT Bangun Akal Indonesia, trading as Building Ai Indonesia, as its sales agent for a two-year term.

The selection follows trials in Indonesia of the EdenCrete products, undertaken by two Indonesian companies which were introduced by Ai Building. Through this, EdenCrete was proven to enable high strength, low Co2, low cost, high-fly ash content concrete mixes to be produced.

Through the appointment, Ai Building has agreed to provide full sales support and introduce customers, and will receive a commission on sales to customers introduced by Ai Building.

Eden Innovations says Indonesia is a target market for EdenCrete products due to its population of more than 275 million people. Indonesia is said to be the fourth largest producer of cement in the world, producing 73 million tonnes of cement in 2020.

Eden Innovations was up 5.88 per cent, trading at 1.8 cents per share at 12:45 pm AEDT.

TAS by the numbers
More From The Market Online
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next
The words "Market Open" appear stacked atop one another next to ASX company iconography.

ASX Market Open: Ever-extending US loss streak to bleed into red Friday – unless Oz bucks trend again | Jan 3, 2024

The ASX 200 is expected to open 0.07% lower at 8,185 points, though after